SG/PUT/NOVO-NORDISK B/900/0.1/21.03.25 Stock

Warrant

DE000SW7ZJM9

Market Closed - Bid/Ask 14:57:07 2024-07-03 EDT
1.08 EUR +13.68% Intraday chart for SG/PUT/NOVO-NORDISK B/900/0.1/21.03.25
Current month+15.05%
1 month-17.05%
Date Price Change
24-07-03 1.08 +13.68%
24-07-02 0.95 +9.20%
24-07-01 0.87 -6.45%
24-06-28 0.93 +2.20%
24-06-27 0.91 0.00%

Real-time Boerse Frankfurt Warrants

Last update July 03, 2024 at 02:57 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ZJM
ISINDE000SW7ZJM9
Date issued 2024-03-20
Strike 900 kr
Maturity 2025-03-21 (261 Days)
Parity 10 : 1
Emission price 1.71
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.01
Lowest since issue 0.8
Delta0x
Omega 0.000000
Premium0x
Gearing11.89x
Moneyness 0.9302
Difference Strike -67.5 kr
Difference Strike %-7.50%
Spread 0.04
Spread %3.60%
Intrinsic value 0.000000
Present value 1.100

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus